agilon health inc (AGL)

Agilon Health's stock price has experienced significant volatility, decreasing by 55.20% over the last 12 months but increasing by 50.46% in the past month. On August 4, 2025, the company announced the departure of its CEO Steven Sell and released second-quarter 2025 earnings results that missed estimates, leading to the withdrawal of its full-year 2025 earnings guidance. This resulted in a substantial drop in the stock price, which closed at $0.88 per share on August 5, 2025. As of January 9, 2026, the share price was $0.99, representing a decline of 65.55% from January 13, 2025.

While specific details on demand seasonality for Agilon Health's products and services are limited, there are indications that seasonality is a factor the company considers. Medical cost trends, which are directly related to the services Agilon Health manages, can have seasonal variations. Tools exist to identify seasonal patterns in AGL's monthly returns, implying that some form of seasonality might be observable in its financial performance, which could be linked to demand.

Agilon Health, Inc. is a healthcare company focused on transforming primary care for seniors through a value-based care model. The company partners with independent primary care physicians, enabling them to transition to a value-based care system. Agilon Health provides a technology-driven platform that integrates data analytics, care coordination, and patient engagement tools. The company assumes financial risk for patient outcomes and offers administrative and operational support, primarily serving Medicare Advantage patients with services like chronic disease management and preventive care.

Agilon Health has a significant and expanding geographic footprint across the United States. As of May 2024, its Physician Network included over 3,000 primary care physicians serving more than 700,000 senior patients in over 30 communities. The company operates in more than 12 states and is set to enter Illinois in 2025 through new partnerships, while also extending its reach in existing states such as Kentucky, Minnesota, and North Carolina. As of September 2025, the company served approximately 618,000 members across more than 30 communities in the United States.

Agilon Health's brand reputation has been significantly impacted by negative events, including legal investigations concerning securities fraud. Multiple law firms have announced investigations into the company for alleged violations of securities laws, focusing on misleading statements and failures to disclose pertinent information to investors. The departure of CEO Steven Sell, coupled with the withdrawal of 2025 financial guidance and disappointing Q2 2025 results, contributed to a substantial drop in stock price and fueled these investigations.

Agilon Health has a substantial number of institutional owners and shareholders, with 374 entities holding a total of 461,833,443 shares, representing approximately 67.57% to 77.55% of the company's stock. Major institutional owners include Clayton, Dubilier & Rice, LLC, Morgan Stanley, and Vanguard Group Inc. Insiders own approximately 2.28% of the stock, while public companies and individual investors hold around 9.98% to 20.17%. Nate Sleeper is noted as owning the most shares of Agilon Health Inc.